Junya Shiota
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junya Shiota has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Keiichi Hashiguchi
Department of Gastroenterology and Hepatology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
5 shared publications - Yuko Akazawa
Department of Histopathology and Cell Biology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
4 shared publications - Maiko Tabuchi
Department of Gastroenterology and Hepatology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
3 shared publications - Hiroki Sato
Division of Gastroenterology & Hepatology, Graduate School of Medicine, Dentistry, and Health Sciences, Niigata University, Niigata, Japan
2 shared publications Hisamitsu Miyaaki
Nagasaki Daigaku Byoin
2 shared publications- Hisamitsu Miyaaki
Department of Gastroenterology and Hepatology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
2 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Wiley in Histopathology
Comprehensive phenotyping of intratumoral fibrosis in gastric carcinomas with poorly differentiated histology: associations with clinicopathological features
Background: Fibrosis is a prominent component of the gastric cancer microenvironment; however, its intratumoral patterns remain poorly characterized. In this study, we employed multidimensional phenotypic profiling to provide a comprehensive characterization of tumour‐associated fibrosis and evaluate its association with histological subtypes and clinical outcomes in gastric carcinomas with poorly differentiated histology. Methods: Of the 392 patients with gastric cancer who underwent gastrectomy at our centre during the study period, 30 patients with T3 tumours were selected for analysis, comprising signet‐ring cell carcinoma (SRC), poorly differentiated adenocarcinoma, non‐solid type (por2), as well as poorly differentiated adenocarcinoma, solid type (por1). Fibrosis phenotypes were quantified using FibroNest™, a digital pathology platform enabling single‐fibre assessment of collagen quantity, morphology and structural organization. Key quantitative fibrosis traits (qFTs) were integrated into a phenotypic fibrosis composite score for gastric cancer (Ph‐FC‐GC). Results: Ph‐FCS‐GC differentiated the overall fibrosis patterns of por1 from those of SRC and por2, although no clear differences in individual fibrosis features were observed between por2 and SRC. Importantly, Ph‐FCS‐GC also effectively discriminated between tumours with and without lymph node metastasis. qFT analysis revealed previously uncharacterized heterogeneity in collagen morphometrics, such as fibre length and branching, in non‐metastatic tumours, whereas metastatic tumours showed more uniform architectures. Tumours with 3‐year recurrence exhibited lower porous area ratios and more spatially ordered collagen networks, indicating denser, more organized fibrosis than non‐recurrent tumours. Conclusions: Collagen morphology and architecture differ according to histological subtype and may provide prognostic insights into lymph node metastasis and recurrence in gastric cancer.
- 11 November 2026
- Published by Wiley in Histopathology
Open AccessComprehensive phenotyping of intratumoral fibrosis in gastric carcinomas with poorly differentiated histology: associations with clinicopathological features
Background: Fibrosis is a prominent component of the gastric cancer microenvironment; however, its intratumoral patterns remain poorly characterized. In this study, we employed multidimensional phenotypic profiling to provide a comprehensive characterization of tumour‐associated fibrosis and evaluate its association with histological subtypes and clinical outcomes in gastric carcinomas with poorly differentiated histology. Methods: Of the 392 patients with gastric cancer who underwent gastrectomy at our centre during the study period, 30 patients with T3 tumours were selected for analysis, comprising signet‐ring cell carcinoma (SRC), poorly differentiated adenocarcinoma, non‐solid type (por2), as well as poorly differentiated adenocarcinoma, solid type (por1). Fibrosis phenotypes were quantified using FibroNest™, a digital pathology platform enabling single‐fibre assessment of collagen quantity, morphology and structural organization. Key quantitative fibrosis traits (qFTs) were integrated into a phenotypic fibrosis composite score for gastric cancer (Ph‐FC‐GC). Results: Ph‐FCS‐GC differentiated the overall fibrosis patterns of por1 from those of SRC and por2, although no clear differences in individual fibrosis features were observed between por2 and SRC. Importantly, Ph‐FCS‐GC also effectively discriminated between tumours with and without lymph node metastasis. qFT analysis revealed previously uncharacterized heterogeneity in collagen morphometrics, such as fibre length and branching, in non‐metastatic tumours, whereas metastatic tumours showed more uniform architectures. Tumours with 3‐year recurrence exhibited lower porous area ratios and more spatially ordered collagen networks, indicating denser, more organized fibrosis than non‐recurrent tumours. Conclusions: Collagen morphology and architecture differ according to histological subtype and may provide prognostic insights into lymph node metastasis and recurrence in gastric cancer.
- Open Access
- 22 January 2026
- Published by Wiley
Perioperative management of hereditary angioedema during endoscopic and surgical procedures under long-term lanadelumab prophylaxis: a case report
- 22 January 2026
- Published by Wiley
Open AccessPerioperative management of hereditary angioedema during endoscopic and surgical procedures under long-term lanadelumab prophylaxis: a case report
- Open Access
- 1 January 2026
- Published by S. Karger AG in Inflammatory Intestinal Diseases
- Vol. 11 (1) , 100-109
Upadacitinib Treatment Outcomes in Crohn’s Disease: A Retrospective Analysis of Clinical Response and Perianal Fistula Resolution
Introduction: Upadacitinib (UPA), a Janus kinase inhibitor approved for the treatment of Crohn’s disease (CD), has demonstrated high efficacy in clinical trials; however, real-world data on its outcomes remain limited. This study evaluated UPA outcomes in patients with CD in a real-world setting. Methods: We retrospectively analyzed patients who initiated UPA treatment between June 2023 and June 2024. The primary endpoints were clinical response and remission at 12 and 54 weeks. The secondary endpoints included changes in the C-reactive protein (CRP) levels, serum albumin levels, and perianal fistula response. Results: Thirteen patients (mean age, 32.0 years; 92.3% male; mean disease duration, 114.1 months) were included. At baseline, three (23.1%) patients used oral corticosteroids, and 11 (84.6%) had undergone prior biologic therapy, with nine (81.8%) exposed to anti-tumor necrosis factor-alpha antibodies. The mean follow-up period was 53.1 weeks, and the 54-week continuation rate was 83.3%. The clinical response rates were 46.2% and 53.8%, and the remission rates were 69.2% and 84.6% at 12 and 54 weeks, respectively. The mean Crohn’s Disease Activity Index scores decreased from 226.8 at baseline to 73.7 at 54 weeks, and the average CRP and albumin levels improved correspondingly. Among the 7 patients (53.8%) with draining perianal fistulas, six (85.7%) achieved cessation of pus discharge by week 8 (mean, 4.4 weeks). No significant adverse events were observed. Conclusion: UPA appears to be an effective treatment for CD and may facilitate the early resolution of perianal fistulas, supporting its role in managing perianal disease.
- 1 January 2026
- Published by S. Karger AG in Inflammatory Intestinal Diseases
- Vol. 11 (1) , 100-109
Open AccessUpadacitinib Treatment Outcomes in Crohn’s Disease: A Retrospective Analysis of Clinical Response and Perianal Fistula Resolution
Introduction: Upadacitinib (UPA), a Janus kinase inhibitor approved for the treatment of Crohn’s disease (CD), has demonstrated high efficacy in clinical trials; however, real-world data on its outcomes remain limited. This study evaluated UPA outcomes in patients with CD in a real-world setting. Methods: We retrospectively analyzed patients who initiated UPA treatment between June 2023 and June 2024. The primary endpoints were clinical response and remission at 12 and 54 weeks. The secondary endpoints included changes in the C-reactive protein (CRP) levels, serum albumin levels, and perianal fistula response. Results: Thirteen patients (mean age, 32.0 years; 92.3% male; mean disease duration, 114.1 months) were included. At baseline, three (23.1%) patients used oral corticosteroids, and 11 (84.6%) had undergone prior biologic therapy, with nine (81.8%) exposed to anti-tumor necrosis factor-alpha antibodies. The mean follow-up period was 53.1 weeks, and the 54-week continuation rate was 83.3%. The clinical response rates were 46.2% and 53.8%, and the remission rates were 69.2% and 84.6% at 12 and 54 weeks, respectively. The mean Crohn’s Disease Activity Index scores decreased from 226.8 at baseline to 73.7 at 54 weeks, and the average CRP and albumin levels improved correspondingly. Among the 7 patients (53.8%) with draining perianal fistulas, six (85.7%) achieved cessation of pus discharge by week 8 (mean, 4.4 weeks). No significant adverse events were observed. Conclusion: UPA appears to be an effective treatment for CD and may facilitate the early resolution of perianal fistulas, supporting its role in managing perianal disease.
- Open Access
- 17 November 2025
- Published by Springer Nature in Research Square
Cadaver-based therapeutic endoscopic training for peroral endoscopic myotomy: A realistic model for skill acquisition
The rarity of achalasia has led to limited opportunities for practical training in educational environments. Cadaver surgical training was developed to enhance surgical skills by providing physicians with experience comparable to that of on-the-job training using structures identical to living organs, thereby proving highly beneficial. Recently, cadavers have been preserved using the Thiel method, which maintains both mobility and organizational flexibility. However, there are few reports on therapeutic endoscopy, including peroral endoscopic myotomy, in the context of cadaver surgical training. We investigated the feasibility of using cadaver surgical training for therapeutic endoscopy training, termed Cadaver-based Therapeutic Endoscopy Training, for peroral endoscopic myotomy. This study was conducted in 2024 at the Cadaver Surgical Center of Nagasaki University using four cadavers preserved using the Thiel method. We performed peroral endoscopic myotomies on three cadavers and evaluated the observability of the esophageal mucosa, penetration of the local injection fluid, feasibility of creating a submucosal tunnel, visibility of indocyanine green injection, and inner circular muscle incision. The layered structure of the digestive tract was well preserved in the Thiel-fixed cadavers, and peroral endoscopic myotomy was performed without major issues. Cadaver-based Therapeutic Endoscopy Training may serve as a realistic training model comparable to living organs and may be beneficial for peroral endoscopic myotomy training.
- 17 November 2025
- Published by Springer Nature in Research Square
Open AccessCadaver-based therapeutic endoscopic training for peroral endoscopic myotomy: A realistic model for skill acquisition
The rarity of achalasia has led to limited opportunities for practical training in educational environments. Cadaver surgical training was developed to enhance surgical skills by providing physicians with experience comparable to that of on-the-job training using structures identical to living organs, thereby proving highly beneficial. Recently, cadavers have been preserved using the Thiel method, which maintains both mobility and organizational flexibility. However, there are few reports on therapeutic endoscopy, including peroral endoscopic myotomy, in the context of cadaver surgical training. We investigated the feasibility of using cadaver surgical training for therapeutic endoscopy training, termed Cadaver-based Therapeutic Endoscopy Training, for peroral endoscopic myotomy. This study was conducted in 2024 at the Cadaver Surgical Center of Nagasaki University using four cadavers preserved using the Thiel method. We performed peroral endoscopic myotomies on three cadavers and evaluated the observability of the esophageal mucosa, penetration of the local injection fluid, feasibility of creating a submucosal tunnel, visibility of indocyanine green injection, and inner circular muscle incision. The layered structure of the digestive tract was well preserved in the Thiel-fixed cadavers, and peroral endoscopic myotomy was performed without major issues. Cadaver-based Therapeutic Endoscopy Training may serve as a realistic training model comparable to living organs and may be beneficial for peroral endoscopic myotomy training.
- Open Access
- 26 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (5) , 1317
Characteristics and Risk Factors of Delayed Perforation in Endoscopic Submucosal Dissection for Early Gastric Cancer
(1) Background: Delayed perforation after gastric endoscopic submucosal dissection (ESD) for early gastric cancer is a relatively uncommon and serious complication that sometimes requires emergency surgery. This study aimed to determine the clinicopathological features, risk factors, and appropriate management strategies for delayed perforation. (2) Methods: This study included 735 patients with 791 lesions who underwent ESD for early gastric cancer at a single institution between July 2009 and June 2019. We retrospectively compared the clinical features of patients with and without delayed perforations. (3) Results: The incidence of delayed perforations was 0.91%. The identified risk factors included a postoperative stomach condition and histopathological ulceration. A comparison between delayed and intraoperative perforations revealed a postoperative stomach condition as a characteristic risk factor for delayed perforation. Patients with delayed perforation who avoided emergency surgery tended to exhibit an earlier onset of symptoms such as abdominal pain and fever. No peritoneal seeding following delayed perforation was observed for any patient. (4) Conclusions: A postoperative stomach condition and histopathological ulceration were risk factors for delayed perforation. Delayed perforation is a significant complication that requires careful monitoring after gastric ESD for early gastric cancer, particularly in patients with postoperative gastric conditions.
- 26 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (5) , 1317
Open AccessCharacteristics and Risk Factors of Delayed Perforation in Endoscopic Submucosal Dissection for Early Gastric Cancer
(1) Background: Delayed perforation after gastric endoscopic submucosal dissection (ESD) for early gastric cancer is a relatively uncommon and serious complication that sometimes requires emergency surgery. This study aimed to determine the clinicopathological features, risk factors, and appropriate management strategies for delayed perforation. (2) Methods: This study included 735 patients with 791 lesions who underwent ESD for early gastric cancer at a single institution between July 2009 and June 2019. We retrospectively compared the clinical features of patients with and without delayed perforations. (3) Results: The incidence of delayed perforations was 0.91%. The identified risk factors included a postoperative stomach condition and histopathological ulceration. A comparison between delayed and intraoperative perforations revealed a postoperative stomach condition as a characteristic risk factor for delayed perforation. Patients with delayed perforation who avoided emergency surgery tended to exhibit an earlier onset of symptoms such as abdominal pain and fever. No peritoneal seeding following delayed perforation was observed for any patient. (4) Conclusions: A postoperative stomach condition and histopathological ulceration were risk factors for delayed perforation. Delayed perforation is a significant complication that requires careful monitoring after gastric ESD for early gastric cancer, particularly in patients with postoperative gastric conditions.
- 1 December 2023
- Published by Wiley in Digestive Endoscopy
- Vol. 36 (7) , 789-800
Achalasia phenotypes and prediction of peroral endoscopic myotomy outcomes using machine learning
Objectives: High‐resolution manometry (HRM) and esophagography are used for achalasia diagnosis; however, achalasia phenotypes combining esophageal motility and morphology are unknown. Moreover, predicting treatment outcomes of peroral endoscopic myotomy (POEM) in treatment‐naïve patients remains an unmet need.Methods: In this multicenter cohort study, we included 1824 treatment‐naïve patients diagnosed with achalasia. In total, 1778 patients underwent POEM. Clustering by machine learning was conducted to identify achalasia phenotypes using patients' demographic data, including age, sex, disease duration, body mass index, and HRM/esophagography findings. Machine learning models were developed to predict persistent symptoms (Eckardt score ≥3) and reflux esophagitis (RE) (Los Angeles grades A–D) after POEM.Results: Machine learning identified three achalasia phenotypes: phenotype 1, type I achalasia with a dilated esophagus (n = 676; 37.0%); phenotype 2, type II achalasia with a dilated esophagus (n = 203; 11.1%); and phenotype 3, late‐onset type I–III achalasia with a nondilated esophagus (n = 619, 33.9%). Types I and II achalasia in phenotypes 1 and 2 exhibited different clinical characteristics from those in phenotype 3, implying different pathophysiologies within the same HRM diagnosis. A predictive model for persistent symptoms exhibited an area under the curve of 0.70. Pre‐POEM Eckardt score ≥6 was the greatest contributing factor for persistent symptoms. The area under the curve for post‐POEM RE was 0.61.Conclusion: Achalasia phenotypes combining esophageal motility and morphology indicated multiple disease pathophysiologies. Machine learning helped develop an optimal risk stratification model for persistent symptoms with novel insights into treatment resistance factors.
- 1 December 2023
- Published by Wiley in Digestive Endoscopy
- Vol. 36 (7) , 789-800
Achalasia phenotypes and prediction of peroral endoscopic myotomy outcomes using machine learning
Objectives: High‐resolution manometry (HRM) and esophagography are used for achalasia diagnosis; however, achalasia phenotypes combining esophageal motility and morphology are unknown. Moreover, predicting treatment outcomes of peroral endoscopic myotomy (POEM) in treatment‐naïve patients remains an unmet need.Methods: In this multicenter cohort study, we included 1824 treatment‐naïve patients diagnosed with achalasia. In total, 1778 patients underwent POEM. Clustering by machine learning was conducted to identify achalasia phenotypes using patients' demographic data, including age, sex, disease duration, body mass index, and HRM/esophagography findings. Machine learning models were developed to predict persistent symptoms (Eckardt score ≥3) and reflux esophagitis (RE) (Los Angeles grades A–D) after POEM.Results: Machine learning identified three achalasia phenotypes: phenotype 1, type I achalasia with a dilated esophagus (n = 676; 37.0%); phenotype 2, type II achalasia with a dilated esophagus (n = 203; 11.1%); and phenotype 3, late‐onset type I–III achalasia with a nondilated esophagus (n = 619, 33.9%). Types I and II achalasia in phenotypes 1 and 2 exhibited different clinical characteristics from those in phenotype 3, implying different pathophysiologies within the same HRM diagnosis. A predictive model for persistent symptoms exhibited an area under the curve of 0.70. Pre‐POEM Eckardt score ≥6 was the greatest contributing factor for persistent symptoms. The area under the curve for post‐POEM RE was 0.61.Conclusion: Achalasia phenotypes combining esophageal motility and morphology indicated multiple disease pathophysiologies. Machine learning helped develop an optimal risk stratification model for persistent symptoms with novel insights into treatment resistance factors.
- 28 January 2023
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (7) , 813-821
‘Underwater endoscopic mucosal resection with submucosal injection and marking’ for superficial non-ampullary duodenal epithelial tumors to achieve R0 resection: a single-center case series
To describe an endoscopic technique named ‘underwater endoscopic mucosal resection (UEMR) with submucosal injection and marking (UEMR-SIM)’ and to evaluate the therapeutic characteristics of superf...
- 28 January 2023
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (7) , 813-821
‘Underwater endoscopic mucosal resection with submucosal injection and marking’ for superficial non-ampullary duodenal epithelial tumors to achieve R0 resection: a single-center case series
To describe an endoscopic technique named ‘underwater endoscopic mucosal resection (UEMR) with submucosal injection and marking (UEMR-SIM)’ and to evaluate the therapeutic characteristics of superf...
- 23 December 2021
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 35 (6)
Geriatric patients with esophageal motility disorders benefit more from minimally invasive peroral endoscopic myotomy: a multicenter study in Japan
Geriatric patients with existing studies on the safety and efficacy of peroral endoscopic myotomy (POEM) for achalasia involve small sample sizes and single institutions. However, multi-center, large-scale data analyses are lacking. The study aimed to clarify the characteristics of geriatric patients with esophageal motility disorders (EMDs) and determine the procedure-related outcomes and clinical course following POEM. This cohort study included 2,735 patients with EMDs who were treated at seven Japanese facilities between 2010 and 2019. The patients’ characteristics and post-POEM clinical courses were compared between the geriatric (age ≥ 75 years; n = 321) and non-geriatric (age < 75 years; n = 2,414) groups. Compared with the non-geriatric group, the geriatric group had higher American Society of Anesthesiologists physical status scores; more recurrent cases; lower incidence of chest pain; and higher incidence of type III achalasia, distal esophageal spasm, and Jackhammer esophagus. Furthermore, the incidence of sigmoid esophagus was higher, although esophageal dilation was not severe in this group. POEM was safe and effective for geriatric patients with treatment-naïve and recurrent EMDs. Furthermore, compared with the non-geriatric group, the geriatric group had lower post-POEM Eckardt scores, fewer complaints of refractory chest pain, and a lower incidence rate of post-POEM reflux esophagitis. Geriatric patients are characterized by worse clinical conditions, more spastic disorders, and greater disease progression of EMDs, which are also the indications for minimally invasive POEM. POEM is more beneficial in geriatric patients as it has lowering symptom scores and incidence rates of reflux esophagitis.
- 23 December 2021
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 35 (6)
Geriatric patients with esophageal motility disorders benefit more from minimally invasive peroral endoscopic myotomy: a multicenter study in Japan
Geriatric patients with existing studies on the safety and efficacy of peroral endoscopic myotomy (POEM) for achalasia involve small sample sizes and single institutions. However, multi-center, large-scale data analyses are lacking. The study aimed to clarify the characteristics of geriatric patients with esophageal motility disorders (EMDs) and determine the procedure-related outcomes and clinical course following POEM. This cohort study included 2,735 patients with EMDs who were treated at seven Japanese facilities between 2010 and 2019. The patients’ characteristics and post-POEM clinical courses were compared between the geriatric (age ≥ 75 years; n = 321) and non-geriatric (age < 75 years; n = 2,414) groups. Compared with the non-geriatric group, the geriatric group had higher American Society of Anesthesiologists physical status scores; more recurrent cases; lower incidence of chest pain; and higher incidence of type III achalasia, distal esophageal spasm, and Jackhammer esophagus. Furthermore, the incidence of sigmoid esophagus was higher, although esophageal dilation was not severe in this group. POEM was safe and effective for geriatric patients with treatment-naïve and recurrent EMDs. Furthermore, compared with the non-geriatric group, the geriatric group had lower post-POEM Eckardt scores, fewer complaints of refractory chest pain, and a lower incidence rate of post-POEM reflux esophagitis. Geriatric patients are characterized by worse clinical conditions, more spastic disorders, and greater disease progression of EMDs, which are also the indications for minimally invasive POEM. POEM is more beneficial in geriatric patients as it has lowering symptom scores and incidence rates of reflux esophagitis.
- 23 April 2019
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 146
Generation of Organoids from Mouse Extrahepatic Bile Ducts
This protocol describes the production of a mouse extrahepatic bile duct 3-dimensional organoid system. These biliary organoids can be maintained in culture to study cholangiocyte biology. Biliary organoids express markers of both progenitor and biliary cells and are composed of polarized epithelial cells.
- 23 April 2019
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 146
Generation of Organoids from Mouse Extrahepatic Bile Ducts
This protocol describes the production of a mouse extrahepatic bile duct 3-dimensional organoid system. These biliary organoids can be maintained in culture to study cholangiocyte biology. Biliary organoids express markers of both progenitor and biliary cells and are composed of polarized epithelial cells.
- Open Access
- 2 October 2013
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2013, 1-7
Magnifying Endoscopic Findings Can Predict Clinical Outcome during Long-Term Follow-Up of More Than 12 Months in Patients with Ulcerative Colitis
Background and Aims. To explore the association of magnifying endoscopic (ME) findings with histopathology and relapse in ulcerative colitis (UC).Methods. Forty-six patients with UC underwent ME with narrow band imaging (NBI) and crystal violet staining and were followed for more than 12 months. ME findings with vital staining were classified into ME-A, regular arrangement of round to oval pits; ME-B, irregular arrangement with/without enlarged spaces between even pits; ME-C, irregular pits in size and shape with more irregular arrangement of pits; and ME-D, disrupted or disappeared pits. NBI-guided ME features of microvascular pattern (MVP) were divided into the MVP-regular and MVP-irregular type.Results. There were 5, 24, 10, and 7 cases of ME-A, ME-B, ME-C, and ME-D grade, respectively, while there were 21 and 25 of MVP-regular and MVP-irregular type, respectively. ME classifications were significantly associated with Matts endoscopic grade. ME classifications and MVP types were significantly associated with each pathognomonic microscopic feature of severe mucosal inflammation, crypt abscess, and goblet cell depletion. There were significant differences in the percentages of remission among ME classifications and between MVP types.Conclusion. ME findings can be predictive of relapse in UC and reliable forin vivohistopathological assessment.
- 2 October 2013
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2013, 1-7
Open AccessMagnifying Endoscopic Findings Can Predict Clinical Outcome during Long-Term Follow-Up of More Than 12 Months in Patients with Ulcerative Colitis
Background and Aims. To explore the association of magnifying endoscopic (ME) findings with histopathology and relapse in ulcerative colitis (UC).Methods. Forty-six patients with UC underwent ME with narrow band imaging (NBI) and crystal violet staining and were followed for more than 12 months. ME findings with vital staining were classified into ME-A, regular arrangement of round to oval pits; ME-B, irregular arrangement with/without enlarged spaces between even pits; ME-C, irregular pits in size and shape with more irregular arrangement of pits; and ME-D, disrupted or disappeared pits. NBI-guided ME features of microvascular pattern (MVP) were divided into the MVP-regular and MVP-irregular type.Results. There were 5, 24, 10, and 7 cases of ME-A, ME-B, ME-C, and ME-D grade, respectively, while there were 21 and 25 of MVP-regular and MVP-irregular type, respectively. ME classifications were significantly associated with Matts endoscopic grade. ME classifications and MVP types were significantly associated with each pathognomonic microscopic feature of severe mucosal inflammation, crypt abscess, and goblet cell depletion. There were significant differences in the percentages of remission among ME classifications and between MVP types.Conclusion. ME findings can be predictive of relapse in UC and reliable forin vivohistopathological assessment.